Yoda Pharmaceuticals Inc. (TPEX:7829)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
58.50
+0.50 (0.86%)
At close: Dec 29, 2025
40.96%
Market Cap4.65B
Revenue (ttm)n/a
Net Income (ttm)-315.73M
Shares Out79.39M
EPS (ttm)-4.35
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume74,722
Average Volume91,371
Open57.80
Previous Close58.00
Day's Range57.80 - 58.60
52-Week Range32.65 - 77.60
Betan/a
RSI49.67
Earnings DateApr 29, 2026

About Yoda Pharmaceuticals

Yoda Pharmaceuticals Inc., an AI-driven company, focuses on advancing drug research and development targeting central nervous system disorders. Its flagship drug, YA-101 is in Phase 2 clinical trial for the treatment of multiple system atrophy. Its development pipeline includes durgs in the field of neurological and psychiatric disorders and cerebrovascular diseases, targeting conditions, such as schizophrenia, Alzheimer's disease, Parkinson‘s disease, Autism, ischemic stroke, and traumatic brain injury. The company was founded in 2019 and is b... [Read more]

Industry Pharmaceutical Preparations
Founded 2019
Country Cayman Islands
Stock Exchange Taipei Exchange
Ticker Symbol 7829
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.